Robust in vitro induction of human germ cell fate from pluripotent stem cells K Sasaki, S Yokobayashi, T Nakamura, I Okamoto, Y Yabuta, K Kurimoto, ... Cell stem cell 17 (2), 178-194, 2015 | 521 | 2015 |
A developmental coordinate of pluripotency among mice, monkeys and humans T Nakamura, I Okamoto, K Sasaki, Y Yabuta, C Iwatani, H Tsuchiya, ... Nature 537 (7618), 57-62, 2016 | 515 | 2016 |
The germ cell fate of cynomolgus monkeys is specified in the nascent amnion K Sasaki, T Nakamura, I Okamoto, Y Yabuta, C Iwatani, H Tsuchiya, ... Developmental cell 39 (2), 169-185, 2016 | 309 | 2016 |
Generation of human oogonia from induced pluripotent stem cells in vitro C Yamashiro, K Sasaki, Y Yabuta, Y Kojima, T Nakamura, I Okamoto, ... Science 362 (6412), 356-360, 2018 | 296 | 2018 |
Toll like receptor-3 ligand poly-ICLC promotes the efficacy of peripheral vaccinations with tumor antigen-derived peptide epitopes in murine CNS tumor models X Zhu, F Nishimura, K Sasaki, M Fujita, JE Dusak, J Eguchi, ... Journal of translational medicine 5 (1), 1-15, 2007 | 231 | 2007 |
Dicer-regulated microRNAs 222 and 339 promote resistance of cancer cells to cytotoxic T-lymphocytes by down-regulation of ICAM-1 R Ueda, G Kohanbash, K Sasaki, M Fujita, X Zhu, ER Kastenhuber, ... Proceedings of the National Academy of Sciences 106 (26), 10746-10751, 2009 | 208 | 2009 |
Evolutionarily distinctive transcriptional and signaling programs drive human germ cell lineage specification from pluripotent stem cells Y Kojima, K Sasaki, S Yokobayashi, Y Sakai, T Nakamura, Y Yabuta, ... Cell stem cell 21 (4), 517-532. e5, 2017 | 170 | 2017 |
Systemic inhibition of transforming growth factor-β in glioma-bearing mice improves the therapeutic efficacy of glioma-associated antigen peptide vaccines R Ueda, M Fujita, X Zhu, K Sasaki, ER Kastenhuber, G Kohanbash, ... Clinical Cancer Research 15 (21), 6551-6559, 2009 | 146 | 2009 |
Bone morphogenetic protein and retinoic acid synergistically specify female germ‐cell fate in mice H Miyauchi, H Ohta, S Nagaoka, F Nakaki, K Sasaki, K Hayashi, Y Yabuta, ... The EMBO journal 36 (21), 3100-3119, 2017 | 133 | 2017 |
Effective immunotherapy against murine gliomas using type 1 polarizing dendritic cells—significant roles of CXCL10 M Fujita, X Zhu, R Ueda, K Sasaki, G Kohanbash, ER Kastenhuber, ... Cancer research 69 (4), 1587-1595, 2009 | 130 | 2009 |
Inhibition of STAT3 promotes the efficacy of adoptive transfer therapy using type-1 CTLs by modulation of the immunological microenvironment in a murine intracranial glioma M Fujita, X Zhu, K Sasaki, R Ueda, KL Low, IF Pollack, H Okada The Journal of Immunology 180 (4), 2089-2098, 2008 | 116 | 2008 |
Reconstitution of prospermatogonial specification in vitro from human induced pluripotent stem cells YS Hwang, S Suzuki, Y Seita, J Ito, Y Sakata, H Aso, K Sato, BP Hermann, ... Nature communications 11 (1), 1-17, 2020 | 104 | 2020 |
miR-17-92 expression in differentiated T cells-implications for cancer immunotherapy K Sasaki, G Kohanbash, A Hoji, R Ueda, HA McDonald, TA Reinhart, ... Journal of translational medicine 8 (1), 1-12, 2010 | 91 | 2010 |
Preferential expression of very late antigen-4 on type 1 CTL cells plays a critical role in trafficking into central nervous system tumors K Sasaki, X Zhu, C Vasquez, F Nishimura, JE Dusak, J Huang, M Fujita, ... Cancer Research 67 (13), 6451-6458, 2007 | 77 | 2007 |
Generation of human oogonia from induced pluripotent stem cells in culture C Yamashiro, K Sasaki, S Yokobayashi, Y Kojima, M Saitou Nature protocols 15 (4), 1560-1583, 2020 | 67 | 2020 |
Single-cell transcriptome of early embryos and cultured embryonic stem cells of cynomolgus monkeys T Nakamura, Y Yabuta, I Okamoto, K Sasaki, C Iwatani, H Tsuchiya, ... Scientific data 4 (1), 1-9, 2017 | 51 | 2017 |
Stat6 signaling suppresses VLA-4 expression by CD8+ T cells and limits their ability to infiltrate tumor lesions in vivo K Sasaki, X Zhao, AD Pardee, R Ueda, M Fujita, S Sehra, MH Kaplan, ... The Journal of Immunology 181 (1), 104-108, 2008 | 44 | 2008 |
Helper function of memory CD8+ T cells: heterologous CD8+ T cells support the induction of therapeutic cancer immunity Y Nakamura, P Watchmaker, J Urban, B Sheridan, A Giermasz, ... Cancer research 67 (20), 10012-10018, 2007 | 44 | 2007 |
Adrenocortical carcinosarcoma: a case report and review of the literature K Sasaki, M Desimone, HR Rao, GJ Huang, RR Seethala Diagnostic pathology 5 (1), 1-7, 2010 | 43 | 2010 |
Spontaneous immune responses against glioma-associated antigens in a long term survivor with malignant glioma R Ueda, KL Low, X Zhu, M Fujita, K Sasaki, TL Whiteside, LH Butterfield, ... Journal of translational medicine 5 (1), 1-11, 2007 | 43 | 2007 |